Search Everything in One Place

Explore the web, images, videos, news, and more – all in one place.

Finance

Alphabet earnings jitters: The greatest cash machine ever still doesn't have enough

A smartphone displays Alphabet in red text, with Sundar Pichai and the Google logo blurred in the background.
A smartphone displays Alphabet in red text, with Sundar Pichai and the Google logo blurred in the background.

Wall Street has spent the week bracing for a number, and the nervousness is not really about whether Alphabet Inc GOOGL GOOG made money. It is about whether making an extraordinary amount of it is still enough. GOOGL stock is moving ahead of earnings. See the chart and price action here. When the Google parent reports second-quarter results after Wednesday’s close, investors will be studying a company that occupies a strange position: fabulously...

Wall Street has spent the week bracing for a number, and the nervousness is not really about whether Alphabet Inc GOOGL GOOG made money. It is about whether making an extraordinary amount of it is still enough.

When the Google parent reports second-quarter results after Wednesday’s close, investors will be studying a company that occupies a strange position: fabulously cash-rich, and yet visibly stretched by the scale of its own ambitions.

The financial newsletter Swiss Transparent Portfolio, in a preview published this week, put the paradox at the center of the moment. 

“The most self-funding company on earth passed the hat,” the publication wrote. “That is the tension the market brings to Wednesday’s print.”

The tension is worth sitting with, because the raw numbers are staggering. By the newsletter’s calculation, “Alphabet generated $174 billion of operating cash flow over the last twelve months. It is, by that measure, the greatest cash machine in corporate history.”

Companies that generate cash on that scale are not supposed to feel constrained by anything. Alphabet, right now, does — and that gap between what it earns and what it wants to spend is precisely what has investors on edge heading into the print.

What Would Validate the Bulls

The disagreement about what it all means is unusually sharp. On one side sit the optimists, who read the heavy spending as a rational response to demand the company simply cannot satisfy fast enough. 

As Swiss Transparent Portfolio framed the bull case, “Bulls see a $460+ billion Cloud backlog, six years of current Cloud revenue already contracted, and a management team told by its own customers that demand is constrained only by capacity.” 

In that telling, the spending is not a warning sign at all. It is a company sprinting to keep up with orders already on the books.

What Would Empower the Bears

The skeptics see the same picture and flinch. The newsletter summarized their concerns bluntly: “Bears see $750+ billion of combined Big Tech capex this year, a depreciation bill rising ~$13 billion, fresh dilution, and a Gemini 3.5 Pro delay that just knocked 3% off the stock.” 

Each item on that list chips away at the bull story — a mounting cost base, shares that no longer feel quite as scarce, and a reminder, in the Gemini stumble, that even the most lavishly funded ambitions can slip.

What makes today so uncomfortable is that both readings are credible, and the print could tip the balance either way. 

Strong cloud growth and disciplined guidance would hand the bulls their proof. Any softness — in cloud, in margins, in the tone around future spending — would let the bears press their case. 

The newsletter captured the resulting paralysis well: “This is exactly the kind of moment where most investors freeze: a wonderful business, a staggering bet, and no consensus on which chart matters.”

That is the real source of the jitters. Alphabet’s earnings power has never been in doubt. Whether that power is finally big enough to cover its appetite is the question the market cannot answer until the numbers land — and it is exactly the question tonight is built to settle.

GOOGL Stock Price Activity: Alphabet shares were up 0.35% at $348.35 at the time of publication Wednesday, according to data from Benzinga Pro.

Over the past month, GOOGL has declined about 2.7% versus a 0.1% rise in the S&P 500 and is up roughly 10% year-to-date compared to the index’s 9.2% gain.

Photo: Shutterstock

SPONSORED

Retirement can be a difficult part of life to navigate, and a financial advisor can help. Finding a qualified financial advisor doesn't have to be hard. SmartAsset's free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you're ready to find an advisor who can help you achieve your financial goals, get started now.

This article Alphabet Earnings Jitters: The Greatest Cash Machine Ever Still Doesn't Have Enough originally appeared on Benzinga.com.

Read full story on Benzinga

Related News

More stories you might be interested in.

What's going on with QuantumScape stock?
Benzinga·1 hour ago

What's going on with QuantumScape stock?

QuantumScape Corp QS shares are slipping Wednesday. Investors may be positioning ahead of the solid-state battery developer’s second-quarter earnings release, scheduled for after today’s closing bell. QuantumScape shares are under pressure. Why is QS stock trading lower? Pre-Earnings Caution Hits QS With results due after the close, traders appear to be reducing exposure rather than carrying risk into the print. Wall Street is forecasting a loss...

Why is UiPath stock falling Wednesday?
Benzinga·1 hour ago

Why is UiPath stock falling Wednesday?

UiPath Inc. PATH stock traded sharply lower on Wednesday after OpenAI introduced a new enterprise automation product, adding to investor concerns that advances in artificial intelligence could intensify competition in workflow automation software. OpenAI Launches Presence OpenAI on Wednesday launched Presence, an enterprise platform that helps companies deploy AI agents across customer service and internal workflows with built-in policies,...

FDA greenlights GSK’s first lung cancer drug ahead of schedule
Benzinga·1 hour ago

FDA greenlights GSK’s first lung cancer drug ahead of schedule

On Wednesday, the U.S. Food and Drug Administration (FDA) granted early approval to GSK plc’s GSK targeted lung cancer medication, Jideytro (zidesamtinib). The regulatory green light authorizes the therapy for adult patients facing locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have previously undergone treatment with a ROS1 kinase inhibitor. Significantly, the agency issued its approval ahead of the original...

Jamie Dimon says it's 'kind of annoying' to watch the rich get 'unbelievably wealthy' when you’re just an 'average citizen'
Benzinga·1 hour ago

Jamie Dimon says it's 'kind of annoying' to watch the rich get 'unbelievably wealthy' when you’re just an 'average citizen'

The gap between the haves and have-nots isn’t just measured in dollars. Sometimes it’s measured by how different two people can experience the same economy. JPMorgan Chase JPM CEO Jamie Dimon believes that’s exactly what’s happening in the U.S. —and he says it’s no surprise that many people feel frustrated watching billionaires amass fortunes while struggling communities continue to fall behind. "The piece that’s really important is that we have...

Top